• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization.转录诱导的 PH 结构域家族 A 成员 1 通过抑制受体寡聚化来减弱表皮生长因子受体的活性。
J Biol Chem. 2018 Feb 9;293(6):2206-2218. doi: 10.1074/jbc.M117.778399. Epub 2017 Dec 12.
2
Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.荧光素酶互补成像技术分析表皮生长因子(EGF)受体-ErbB2-ErbB3 蛋白网络的动态变化
J Biol Chem. 2013 Oct 18;288(42):30773-30784. doi: 10.1074/jbc.M113.489534. Epub 2013 Sep 6.
3
Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.ERBB3的寡聚体有两个不同的界面,它们对heregulin破坏的敏感性不同。
J Biol Chem. 2005 Mar 4;280(9):8238-47. doi: 10.1074/jbc.M410944200. Epub 2004 Dec 20.
4
Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.黏附分子 Nectin-样分子 4/细胞黏附分子 4 抑制配体诱导的 ErbB3 与 ErbB2 二聚化。
Sci Rep. 2017 Sep 12;7(1):11375. doi: 10.1038/s41598-017-10107-5.
5
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.氟维司群诱导的 ErbB3 和 ErbB4 受体表达使雌激素受体阳性乳腺癌细胞对人表皮生长因子受体 2 配体 β1 敏感。
Breast Cancer Res. 2011 Mar 11;13(2):R29. doi: 10.1186/bcr2848.
6
Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.可溶性 ErbB3 蛋白单 N-糖基化缺失突变体抑制人表皮生长因子受体家族成员 3 配体信号。
J Biol Chem. 2013 Nov 15;288(46):32910-21. doi: 10.1074/jbc.M113.491902. Epub 2013 Oct 4.
7
The neuregulin-I/ErbB signaling system in development and disease.发育与疾病中的神经调节蛋白-I/表皮生长因子受体信号系统
Adv Anat Embryol Cell Biol. 2007;190:1-65.
8
Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.活细胞中单分子分析检测到的肝素结合生长因子和表皮生长因子受体蛋白之间动态变化的相互作用。
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13984-9. doi: 10.1073/pnas.1200464109. Epub 2012 Aug 13.
9
Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.丝裂原活化蛋白激酶和磷酸肌醇3'-激酶在ErbB2/ErbB3共受体介导的这里调节蛋白信号传导中的作用。
Exp Cell Res. 2003 Apr 1;284(2):291-302. doi: 10.1016/s0014-4827(02)00040-x.
10
Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.Heregulin 通过 AKT 介导的途径负调控 ErbB2/3 受体的转录。
J Cell Physiol. 2014 Nov;229(11):1831-41. doi: 10.1002/jcp.24637.

引用本文的文献

1
SOX10-Mediated Regulation of Enteric Glial Phenotype in vitro and its Relevance for Neuroinflammatory Disorders.SOX10介导的肠神经胶质细胞表型的体外调控及其与神经炎症性疾病的相关性
J Mol Neurosci. 2025 Feb 21;75(1):26. doi: 10.1007/s12031-025-02321-y.
2
Expanding on roles of pleckstrin homology-like domain family A member 1 protein.扩展普列克底物蛋白同源结构域样家族A成员1蛋白的作用。
Cell Tissue Res. 2025 Jan;399(1):9-25. doi: 10.1007/s00441-024-03942-2. Epub 2024 Dec 4.
3
FGF10 mitigates doxorubicin-induced myocardial toxicity in mice via activation of FGFR2b/PHLDA1/AKT axis.FGF10 通过激活 FGFR2b/PHLDA1/AKT 轴减轻小鼠多柔比星诱导的心肌毒性。
Acta Pharmacol Sin. 2023 Oct;44(10):2004-2018. doi: 10.1038/s41401-023-01101-x. Epub 2023 May 24.
4
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via Induction.组蛋白去乙酰化酶抑制通过诱导恢复乳腺癌对 HER2 靶向治疗的反应。
Int J Mol Sci. 2023 Mar 25;24(7):6228. doi: 10.3390/ijms24076228.
5
An Analysis Identified Members of the Pleckstrin Homology-Like Domain, Family B (PHLDB family) as Potential Prognostic and Predictive Biomarkers of Treatment Response in Breast Cancer Patients.一项分析确定,普列克底物蛋白同源样结构域B家族(PHLDB家族)的成员是乳腺癌患者治疗反应的潜在预后和预测生物标志物。
Eur J Breast Health. 2022 Jul 1;18(3):235-247. doi: 10.4274/ejbh.galenos.2022.2022-3-5. eCollection 2022 Jul.
6
IκBα is required for full transcriptional induction of some NFκB-regulated genes in response to TNF in MCF-7 cells.IκBα 在 MCF-7 细胞中响应 TNF 时对某些 NFκB 调节基因的完全转录诱导是必需的。
NPJ Syst Biol Appl. 2021 Dec 1;7(1):42. doi: 10.1038/s41540-021-00204-7.
7
A combination approach of pseudotime analysis and mathematical modeling for understanding drug-resistant mechanisms.基于伪时间分析和数学建模的组合方法用于理解耐药机制。
Sci Rep. 2021 Sep 16;11(1):18511. doi: 10.1038/s41598-021-97887-z.
8
A Computational Framework for Prediction and Analysis of Cancer Signaling Dynamics from RNA Sequencing Data-Application to the ErbB Receptor Signaling Pathway.基于RNA测序数据预测和分析癌症信号动力学的计算框架——在表皮生长因子受体(ErbB)信号通路中的应用
Cancers (Basel). 2020 Oct 7;12(10):2878. doi: 10.3390/cancers12102878.
9
Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1.Meta 分析 HIV-1 长期非进展感染者的基因表达谱
BMC Med Genomics. 2019 Jan 9;12(1):3. doi: 10.1186/s12920-018-0443-x.

本文引用的文献

1
PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.PHLDA2是一种关键的癌基因诱导的负反馈抑制剂,通过干扰AKT信号传导来抑制EGFR/ErbB2信号传导。
Oncotarget. 2015 Apr 9;9(38):24914-24926. doi: 10.18632/oncotarget.3674. eCollection 2018 May 18.
2
HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.靶向HER-3会改变乳腺癌中ErbB蛋白家族成员的二聚化模式。
Oncotarget. 2016 Feb 2;7(5):5576-97. doi: 10.18632/oncotarget.6762.
3
Orchestration of ErbB3 signaling through heterointeractions and homointeractions.通过异源相互作用和同源相互作用对ErbB3信号进行调控。
Mol Biol Cell. 2015 Nov 5;26(22):4109-23. doi: 10.1091/mbc.E14-06-1114. Epub 2015 Sep 16.
4
Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells.启动子水平的表达聚类分析确定了乳腺癌细胞中由表皮生长因子受体(ErbB)启动的转录调控级联反应的时间发展过程。
Sci Rep. 2015 Jul 16;5:11999. doi: 10.1038/srep11999.
5
Signalling mechanisms regulating phenotypic changes in breast cancer cells.调节乳腺癌细胞表型变化的信号传导机制。
Biosci Rep. 2015 Mar 18;35(2):e00178. doi: 10.1042/BSR20140172.
6
Feedforward regulation of mRNA stability by prolonged extracellular signal-regulated kinase activity.通过延长细胞外信号调节激酶活性实现对mRNA稳定性的前馈调节。
FEBS J. 2015 Feb;282(4):613-29. doi: 10.1111/febs.13172. Epub 2015 Jan 8.
7
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.ErbB2 阳性癌症中 ErbB2 阻断的调节:ErbB2 突变和 PHLDA1 的作用
PLoS One. 2014 Sep 19;9(9):e106349. doi: 10.1371/journal.pone.0106349. eCollection 2014.
8
PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.PHLDA1的表达受雌激素受体-NFκB-miR-181调控环的控制,并且对于雌激素受体阳性乳腺球的形成至关重要。
Oncogene. 2015 Apr 30;34(18):2309-16. doi: 10.1038/onc.2014.180. Epub 2014 Jun 23.
9
On-beads digestion in conjunction with data-dependent mass spectrometry: a shortcut to quantitative and dynamic interaction proteomics.在珠上消化结合数据依赖的质谱分析:定量和动态相互作用蛋白质组学的捷径。
Biology (Basel). 2014 Apr 16;3(2):320-32. doi: 10.3390/biology3020320.
10
erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.erbB3 是一种具有活性的酪氨酸激酶,能够发生同源和异源相互作用。
Mol Cell Biol. 2014 Mar;34(6):965-77. doi: 10.1128/MCB.01605-13. Epub 2013 Dec 30.

转录诱导的 PH 结构域家族 A 成员 1 通过抑制受体寡聚化来减弱表皮生长因子受体的活性。

Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization.

机构信息

From the Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences (IMS), 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

the Laboratory of Cell Systems, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

出版信息

J Biol Chem. 2018 Feb 9;293(6):2206-2218. doi: 10.1074/jbc.M117.778399. Epub 2017 Dec 12.

DOI:10.1074/jbc.M117.778399
PMID:29233889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5808779/
Abstract

Feedback control is a key mechanism in signal transduction, intimately involved in regulating the outcome of the cellular response. Here, we report a novel mechanism by which PHLDA1, Pleckstrin homology-like domain, family A, member 1, negatively regulates ErbB receptor signaling by inhibition of receptor oligomerization. We have found that the ErbB3 ligand, heregulin, induces expression in MCF-7 cells. Transcriptionally-induced PHLDA1 protein directly binds to ErbB3, whereas knockdown of increases complex formation between ErbB3 and ErbB2. To provide insight into the mechanism for our time-course and single-cell experimental observations, we performed a systematic computational search of network topologies of the mathematical models based on receptor dimer-tetramer formation in the ErbB activation processes. Our results indicate that only a model in which PHLDA1 inhibits formation of both dimers and tetramer can explain the experimental data. Predictions made from this model were further validated by single-molecule imaging experiments. Our studies suggest a unique regulatory feature of PHLDA1 to inhibit the ErbB receptor oligomerization process and thereby control the activity of receptor signaling network.

摘要

反馈控制是信号转导中的一个关键机制,密切参与调节细胞反应的结果。在这里,我们报告了一种新的机制,即 PH-LDA1(pleckstrin homology-like domain,family A,member 1)通过抑制受体寡聚化来负调控 ErbB 受体信号。我们发现 ErbB3 配体 heregulin 诱导 MCF-7 细胞中的表达。转录诱导的 PH-LDA1 蛋白直接结合 ErbB3,而敲低则增加 ErbB3 和 ErbB2 之间的复合物形成。为了深入了解我们的时程和单细胞实验观察的机制,我们对基于 ErbB 激活过程中受体二聚体-四聚体形成的数学模型的网络拓扑结构进行了系统的计算搜索。我们的结果表明,只有一种模型可以解释实验数据,即 PH-LDA1 抑制二聚体和四聚体的形成。该模型的预测结果进一步通过单分子成像实验得到验证。我们的研究表明,PH-LDA1 具有独特的调节功能,可以抑制 ErbB 受体寡聚化过程,从而控制受体信号网络的活性。